Logo

Public Feeds

Public speeches should be public

Politicians, athletes, journalists, NGOs, companies... They all use corporation-owned social networks to communicate with us. Citizens shouldn't have to hand over their data to companies to read content published by public entities. Public Feeds changes that by making posts of popular accounts freely available. Read more.

Imugene

Imugene Ltd is a biotechnology company working in cancer immunotherapy. The company's lead product is HER-Vaxx, a therapeutic cancer vaccine for the treatment of gastric cancer and breast cancer, where the cancer is HER-2-positive. Imugene was planning a Phase Ib/II clinical study of HER-Vaxx in gastric cancer which it intended to initiate in 2016. Imugene stock is publicly traded on the Australian Securities Exchange (ASX). More on Wikipedia